Document is current
Any future updates will be listed below
-
Authors
Huo, Yi
Sheng, Zhen
Lu, Daniel R.
Ellwanger, Daniel C.
Li, Chi-Ming
Homann, Oliver
Wang, Songli
Yin, Hong
Ren, Ruibao
-
Funding
Funding for this research was provided by:
National Key Research and Development Program (2016YFC0902800)
Key Project of Natural Science Foundation of China (81530006)
Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research (2019CXJQ01)
Natural Science Foundation of China (81870112)
the Innovative research team of high-level local universities in Shanghai
- License Information
-
More Information
Article History
Received: 16 September 2020
Accepted: 11 February 2021
First Online: 1 March 2021
Ethics approval and consent to participate
: Not Applicable.
: Not Applicable.
: Disclosure of Conflicts of Interest: Y.H. and Z.S are the joint postdoctoral fellows at Amgen Inc. and Ruijin Hospital. C.L., D.L., D.C.E., O.H., S.W., and H.Y. are employees at Amgen Inc. R.R. is professor at Shanghai Institute of Hematology at Ruijin Hospital. The authors declare no competing interests.
